Notice on Commencement of Mandatory Therapeutic Equivalence Demonstration For Multisource (Generic) Medical Products in Kenya
- Version
- Download 876
- File Size 2.72 MB
- File Count 1
- Create Date October 20, 2023
- Last Updated October 20, 2023
Notice on Commencement of Mandatory Therapeutic Equivalence Demonstration For Multisource (Generic) Medical Products in Kenya
The Pharmacy and Poisons Board (hereinafter referred to as "the Board"), is mandated, under Section 3B(2)(b) of the Pharmacy and Poisons Act (Cap. 244), to ensure that all medical products manufactured in, imported into, or exported from Kenya conform to prescribed standards of quality, safety, and efficacy.
Attached Files
| File | Action |
|---|---|
| Notice on Commencement of Mandatory Therapeutic Equivalence Demonstration For Multisource (Generic) Medical Products in Kenya.pdf | Download |
